Utah Medical Products, Inc. $UTMD Position Raised by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC grew its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 87.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 21,547 shares of the medical instruments supplier’s stock after acquiring an additional 10,065 shares during the quarter. Segall Bryant & Hamill LLC owned about 0.68% of Utah Medical Products worth $1,336,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brandes Investment Partners LP boosted its holdings in shares of Utah Medical Products by 4.0% in the fourth quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier’s stock valued at $19,660,000 after acquiring an additional 13,392 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Utah Medical Products by 1.3% during the 3rd quarter. Dimensional Fund Advisors LP now owns 200,032 shares of the medical instruments supplier’s stock valued at $12,596,000 after purchasing an additional 2,566 shares during the period. Geode Capital Management LLC raised its stake in shares of Utah Medical Products by 6.5% in the 2nd quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier’s stock worth $6,537,000 after buying an additional 7,040 shares in the last quarter. Minerva Advisors LLC raised its position in Utah Medical Products by 0.6% in the fourth quarter. Minerva Advisors LLC now owns 93,615 shares of the medical instruments supplier’s stock worth $5,239,000 after acquiring an additional 557 shares in the last quarter. Finally, Rice Hall James & Associates LLC lifted its holdings in Utah Medical Products by 5.4% in the 1st quarter. Rice Hall James & Associates LLC now owns 67,882 shares of the medical instruments supplier’s stock valued at $4,208,000 after acquiring an additional 3,484 shares during the last quarter. Institutional investors own 69.60% of the company’s stock.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “hold (c-)” rating on shares of Utah Medical Products in a report on Friday, May 22nd. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Hold”.

Utah Medical Products Trading Down 1.5%

NASDAQ:UTMD opened at $71.21 on Thursday. The firm has a market capitalization of $226.73 million, a PE ratio of 21.71 and a beta of 0.35. Utah Medical Products, Inc. has a 1 year low of $53.66 and a 1 year high of $75.75. The firm’s fifty day simple moving average is $68.88 and its 200 day simple moving average is $66.10.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings results on Thursday, July 23rd. The medical instruments supplier reported $0.84 earnings per share (EPS) for the quarter. The company had revenue of $8.53 million during the quarter. Utah Medical Products had a net margin of 29.04% and a return on equity of 8.79%.

Utah Medical Products Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, October 5th. Shareholders of record on Thursday, September 17th will be given a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Thursday, September 17th. Utah Medical Products’s payout ratio is currently 37.80%.

Utah Medical Products Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).